UNSPSC 85893937: Low dose rate (ldr) brachytherapy of cervix using iodine 125 (i-125)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of low dose rate (ldr) brachytherapy of cervix using iodine 125 (i-125). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DU11B9Z

UNSPSC 85893937 Low dose rate brachytherapy of cervix using iodine 125 (I-125) is a Commodity code that nominally addresses a specialized oncologic radiotherapy procedure. Recent state and local procurement activity under this code shows minimal relevant solicitation volume; the most recent opportunity on file is unrelated to the code's stated scope. The County of Santa Clara Health System's July 2026 RFQ for temporary health professional staffing services (due October 7, 2026) addresses ancillary clinical categories including audiology, diagnostic imaging, respiratory care, sterile processing, and surgical services — a workforce-availability function that does not align with the procurement of brachytherapy treatment delivery or supporting oncology services.

The mismatch between the code's technical scope and the recent opportunity suggests either a misclassification in the state or local procurement system or limited current demand for low-dose-rate brachytherapy procurement specifically. Without additional opportunities in the source record that directly address cervical brachytherapy equipment, isotope procurement, or related oncology service delivery, no reliable signal emerges about geographic spread, issuing-body concentration, or active market activity under this code. Business development professionals should verify whether state and local health systems in their target markets are soliciting brachytherapy services separately under different UNSPSC classifications or through standing agreements with regional oncology consortia.